The rheumatology field is undergoing significant advances as new therapeutic approaches—particularly in the area of cell and gene therapy (CGT)—hold the potential to reshape the treatment landscape.
As the industry shifts, it is imperative to explore the complexities of rheumatology to accelerate clinical development and improve the lives of patients with these conditions. In this webinar, the expert speakers will provide a comprehensive overview of the current state of the clinical development landscape for rheumatology, highlighting recent advances broadening the scope of treatment options such as CGT and targeting pathways and mechanisms of action rather than focusing on individual diseases.
While these innovations offer new hope, they present unique challenges such as complex study designs and processes, a competitive environment, patient recruitment and retention and the specialized knowledge and training required to orchestrate these studies. The expert speakers will explore strategies to navigate the challenges of conducting rheumatology studies by leveraging cross-collaborative expertise and strong communication.
Register for this webinar to gain insights and strategies to drive success in rheumatology clinical trials.
Speakers
Dr. Andrew Head, MD, Medical Director, Medpace
Dr. Andrew Head is board-certified in internal medicine and rheumatology with 20 years of prior experience in clinical practice and as a clinical associate professor of medicine. Dr. Head has experience in diagnosis and long-term management of patients with a variety of complicated autoimmune rheumatic diseases.
He has authored or co-authored several publications and presented abstracts at the annual American College of Rheumatology (ACR) meetings. Dr. Head has clinical trial experience as a Medical Monitor, Principal Investigator or Sub-Investigator in several clinical trials covering rheumatology indications.
Message Presenter
Dr. Jeffrey Vassallo, PhD, Senior Director of Clinical Trial Management, Medpace
Dr. Jeffrey Vassallo has a PhD in molecular biology with postdoctoral training in experimental hematology. He has worked in drug development, including pre-clinical and clinical research, for more than 27 years. In this capacity, he led research and project teams internally and in collaboration with scientists and clinicians from pharmaceutical companies, academia and the FDA.
During his tenure at Medpace, Dr. Vassallo has managed global Phase I-III trials in hematology and oncology, with an emphasis in advanced therapies. This diverse experience gives him a unique perspective on the operational aspects in the clinical development of cellular and gene therapies.
Message Presenter
Ms. Jackie Widmer, Director, Clinical Trial Management, Medpace
Ms. Jackie Widmer has over 18 years of global industry experience leading Phase I-IV studies across multiple therapeutic areas, including over 13 years of Medpace global project management in progressive leadership roles. She has over five years of pharmaceutical experience leading global rare disease and gene therapy clinical development programs.
Message Presenter
Ms. Miaesha Campbell, Executive Director, Patient Recruitment, Medpace
Ms. Miaesha Campbell is an accomplished professional with over 17 years of experience directing a global team of strategic partners, support staff and vendors for multimillion-dollar global marketing, patient recruitment and patient retention campaigns.
This includes oversight of the planning and execution of programs with a solution-based approach tailored to the needs of the sites and patients. She has worked on studies across all phases and multiple therapeutic areas using site- and patient-centric strategies to bring clinical trials to patients as a care option.
Message PresenterWho Should Attend?
This webinar will appeal to VPs, Directors, Managers and Department Heads working within:
- Clinical affairs/Clinical research
- Clinical pharmacology/Clinical outsourcing
- Project management
- Regulatory affairs/Medical affairs
What You Will Learn
Attendees will learn about:
- Recent CGT advances in rheumatology
- Operational strategies to navigate the challenges of conducting rheumatology studies
- Patient recruitment and retention approaches
Xtalks Partner
Medpace
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas, including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account